POM Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
POM is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is trading weak in pre-market, the technical trend is bearish, and there is no strong proprietary buy signal from Intellectia. While the latest annual results showed revenue growth and a smaller loss per share, profitability remains weak and the market is still pricing the stock defensively. My direct view: hold off on buying now.
The current setup is bearish. POM is down 4.19% pre-market at 0.128. MACD histogram is negative at -0.0177, though it is contracting, which means downside momentum is still present but easing slightly. RSI_6 at 36.3 is neutral-to-weak, showing no strong reversal signal. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend across multiple timeframes. The pivot at 0.239 is far above the current price, while support at 0.0611 is much lower, indicating the stock is trading in a weak zone with limited near-term technical strength.
["FY 2025 revenue grew 16.7% to RMB 399.9 million.", "Gross profit rose 9.6% to RMB 52.3 million.", "Loss per share improved to RMB 21.96 from RMB 22.72, showing some progress in earnings efficiency."]
["Pre-market price is down 4.19%, showing immediate selling pressure.", "Bearish moving average structure signals the stock remains in a downtrend.", "Gross margin declined to 13.1% from 13.9%, indicating weaker profitability quality.", "No AI Stock Picker signal today.", "No recent SwingMax signal.", "Hedge funds are neutral with no significant accumulation trend.", "Insiders are neutral with no notable buying support.", "No recent congress trading data or influential figure buying activity was reported.", "The stock trend model suggests only modest upside probabilities and weak short-term performance."]
The latest reported quarter information is not available in the provided data, but the most recent full-year financials for FY 2025 show growth with net revenues of RMB 399.9 million, up 16.7% year over year. Gross profit increased 9.6% to RMB 52.3 million, and loss per share improved from RMB 22.72 to RMB 21.96. However, gross margin fell to 13.1% from 13.9%, so while top-line growth is positive, profitability quality remains under pressure.
No analyst rating or price target change data was provided, so there is no visible Wall Street upgrade/downgrade trend to assess. Based on the available data, Wall Street pros would likely be cautious: the pro case is revenue growth and improving losses, while the con case is weak margins, bearish technicals, and lack of strong buying signals.
